tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Tenax Therapeutics Reports Increased Losses Amid Strategic Investments
PremiumCompany AnnouncementsTenax Therapeutics Reports Increased Losses Amid Strategic Investments
3M ago
Positive Buy Rating for Tenax Therapeutics Driven by Promising Clinical Trials and Strong Financial Position
Premium
Ratings
Positive Buy Rating for Tenax Therapeutics Driven by Promising Clinical Trials and Strong Financial Position
3M ago
Tenax Therapeutics price target lowered to $15 from $16 at Guggenheim
Premium
The Fly
Tenax Therapeutics price target lowered to $15 from $16 at Guggenheim
3M ago
Tenax Therapeutics reports Q4 EPS (18c), consensus (43c)
PremiumThe FlyTenax Therapeutics reports Q4 EPS (18c), consensus (43c)
5M ago
Is TENX a Buy, Before Earnings?
Premium
Pre-Earnings
Is TENX a Buy, Before Earnings?
5M ago
Promising Developments and Financial Backing Drive Buy Rating for Tenax Therapeutics
Premium
Ratings
Promising Developments and Financial Backing Drive Buy Rating for Tenax Therapeutics
5M ago
Tenax Therapeutics Appoints Interim CFO Thomas McGauley
PremiumCompany AnnouncementsTenax Therapeutics Appoints Interim CFO Thomas McGauley
9M ago
Tenax Therapeutics reports Q3 EPS (19c) , consensus ($1.39)
Premium
The Fly
Tenax Therapeutics reports Q3 EPS (19c) , consensus ($1.39)
9M ago
Tenax Therapeutics reports Q3 EPS 19c, consensus ($1.39)
Premium
The Fly
Tenax Therapeutics reports Q3 EPS 19c, consensus ($1.39)
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100